The development of small-cell lung cancer (SCLC) is clearly associated with loss-of-function mutations in genes such as tumor protein 53 (TP53) and retinoblastoma 1 (RB1) in PNECs, tuft, club, or AT2 cells. This evidence concerns the gene RB1 and small cell lung carcinoma.